Nebulizers Market to be at Forefront by 2026

Nebulizers are drug
delivery devices that are used to administer medicines in the form of
a mist inhaled into the lungs. This drug delivery method helps in
the administration of drugs such as corticosteroids, bronchodilators
and anti-inflammatory medications. Nebulizers are mainly used for
patients suffering from asthma, cystic fibrosis, chronic obstructive
pulmonary disease (COPD) and other respiratory diseases or disorders.
It is much comfortable to use than other forms of ingested medicines,
as it targets the respiratory area directly, thus reducing side
effects and harm to other body organs and cells. Nebulizers are
especially used for delivery of drug to breathing passages, reduce
bulging of mucous membrane, to reduce irritation caused by pollutants
and activate and thin out discharge. These devices are specially
developed for adults and children who are not able to handle
inhalers.
Get Exclusive
Sample Report at: http://bit.ly/2XbRTXL
The use of nebulizer
depends on the illness for which it is designed to treat. Various
considerations to be taken care of while using a nebulizer are as
follows:
The appropriate
method of using the nebulizer
Ways to keep the
nebulizer clean for maximum safety and effectiveness
Nebulizers Market
taxonomy:
On the basis of
product type, the nebulizers market is classified into:
Ultrasonic
Pneumatic
Mesh
Ultrasonic
nebulizers include portable and standalone nebulizers.
Pneumatic nebulizers
are further classified into:
Breath Actuated
nebulizers
Vented
nebulizers
Also, mesh
nebulizers are also further classified into:
Static type
nebulizers
Vibrating type
nebulizers
Pneumatic nebulizers
hold the major share in nebulizers market due to their ease of
handling, efficient design and low cost.
On the basis of end
user, the nebulizers market is classified into:
Hospitals
Clinics
Ambulatory
Surgical Centers
Home Care
Settings
Product
innovation driving the preference for nebulizers in treating
respiratory conditions
The advanced
nebulizers that features aerosol drug delivery technology with
minimal drug wastage is expected to drive the nebulizers market
growth. Patients play a vigorous role in supervising their diseases
by choosing for devices that assist them in diagnosis and treatment
at the comfort of their own homes. This shift in patient preferences
will strengthen the global nebulizer market growth scenario in the
near future. Also the rise in respiratory cases form a major factor.
According to World Health Organization (WHO), around 15.7 million
people were reported with Chronic Obstructive Pulmonary Disease
(COPD) in the U.S. in 2016 which showed a significant increase of
6.4% from 2015.
Nebulizers are also
for a variety of diagnostic procedures among which the principal one
is in diagnosis of lung function and bronchial activities. This has
also added to the rise in demand for nebulizers in the market by the
professionals for clinical use and monitoring of various associated
respiratory disorders.
Medical
reimbursement supporting the North America nebulizer market growth
There are guidelines
laid for nebulizers which facilitates its proper usage. The Centers
for Medicare & Medicaid Services, and United HealthCare Services,
Inc. have defined guidelines for the proper usage of nebulizers in
different respiratory issues. In addition to that there are various
reimbursement policies that fuel the growth of the market, for
instance, policies by Medicaid & Healthcare Partnership in 2012
helped in the easy purchase of nebulizers. Under Hawaii Medical
Service Association, in 2014, several cover plans were made for the
easy purchases of small volume and large volume nebulizers.
Also, there exists a
rental market for nebulizers that assists the usage of these devices
in home care settings.
Since nebulization
is a spraying technique, therefore the dispersion and wastage of the
drug during delivery to the respiratory tract is one of the major
restraint for the growth of nebulizers market. Moreover, low consumer
switching cost and availability of alternative therapies increases
the threat of substitute products.
Request For
Customization of Research Report @ http://bit.ly/2xlEGvP
By geography,
North America holds the major share in the global nebulizers market
because of the availability of reimbursement and increasing incidence
of respiratory diseases.
Key players in the
global nebulizers market are GE Healthcare Ltd, Agilent Technologies,
GF Health Products, Philips Healthcare CareFusion Corporation, PARI
Respiratory Equipment, Covidien plc and Omron Healthcare Co. The
players are undertaking various clinical trials and development
activities in an endeavor to improve therapeutic effect of the drug.
Theravance Biopharma and Mylan announced the initiation of phase 3
studies of revefenacin at the American Thoracic Society (ATS)
International Conference in 2017. Revefenacin is a once-daily long
acting muscarinic antagonist (LAMA) nebulized therapy. Development of
such drugs intended to be delivered via nebulization will also
support propelling the growth for nebulizers market. Also Vectura
received FDA approval to start testing a smart technology of
nebulizers to improve asthma therapies in children.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment